Delivery Order SPE2DB22D3009-SPE2DB26FAH17
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at approximately $55,954.56 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 MG/ML in pen/milliliter format. This is a firm fixed price, non-set-aside contract with a completion date of September 30, 2025, issued on September 29, 2025. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $42,191.28 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL pen medication on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed price contract represents a non-competitive set-aside delivery against AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $24,614.47 to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML pen/ml on November 7, 2025, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of SKYRIZI 150 MG/ML PenML, a pharmaceutical product, with a ceiling value of $26,166.64. This competitively awarded, firm fixed-price delivery order is set to conclude on August 19, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,119.69 for SKYRIZI 600 mg/10 mL vials on July 14, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price delivery order is not set-aside and represents a competitive award. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office operations. This delivery order is issued...
- The Defense Logistics Agency awarded a $32,133.89 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 MG/ML, a prescription pharmaceutical product. This competitive delivery order, issued on July 15, 2025, with a completion date of July 16, 2025, represents a firm fixed-price transaction with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This...
- The Defense Logistics Agency awarded a $11,830.00 delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for the supply of SKYRIZI 150 MG/ML PenML, a pharmaceutical product. This is a firm fixed-price delivery order with an ultimate completion date of October 21, 2025, and represents a non-set-aside award made through competitive procurement. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of SKYRIZI 600 mg/10 mL vials with a ceiling value of $6,119.68. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The order is scheduled for completion by November 28, 2025, and represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a $41,824.89 delivery order to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/ml pen medication on September 2, 2025, with completion expected by September 3, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under a larger procurement vehicle. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $12,140.62 to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of SKYRIZI 150 MG/ML in pen/milliliter format. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract's ultimate completion date is October 31, 2025, and performance will occur at AmerisourceBergen's corporate...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB26FAH17Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $18,153.63 to AmerisourceBergen Drug Corp for SKYRIZI 150 mg/mL medication on November 5, 2025, with completion expected by November 6, 2025. This firm fixed-price delivery order is non-set-aside and represents a competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999.00 through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor, AmerisourceBergen holds a significant role in the federal medical supply chain, fulfilling orders across multiple therapeutic domains from specialty medications to vaccines and medical devices through the DLA's procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.2k | 11/5/25 |